Clinical Trials Browser

Interventional × Nasopharyngeal Carcinoma × epacadostat × Clear all

NCT04231864 2020-10-26

Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer

Phase 2 Withdrawn

Nasopharyngeal Carcinoma